Press Resease

Proteinase K Market - Global Industry Analysis

Proteinase K Market - By Form (Powder and Liquid), By Therapeutic Area (Neurology, Nephrology, Diabetes, Oncology, Contagious Diseases, Autoimmune Disease, and Cardiology), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Published Date: 21-Jan-2021 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-5465 Status : Published

The global Proteinase K Market, which was estimated at 6.08 (USD Billion) in 2019 and is anticipated to accrue earnings worth 15.7 (USD Billion) by 2026, is set to record a CAGR of nearly 7.5% over 2020-2026.

Description

The global Proteinase K Market, which was estimated at 6.08 (USD Billion) in 2019 and is anticipated to accrue earnings worth 15.7 (USD Billion) by 2026, is set to record a CAGR of nearly 7.5% over 2020-2026. The report offers valuation and analysis of Proteinase K market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2019 along with a forecast from 2020 to 2026 based on value (USD Billion).

Proteinase K Market: Overview & Insights

Proteinase K is a broad-spectrum of serine protease and it was discovered in 1974 from fungus engyodontium extracts. Furthermore, the enzyme has the ability of digesting hair protein referred as keratin. The product is utilized in molecular biology for digesting protein and removing contamination occurring during preparing nucleic acids. The proteinase K enzyme is utilized for destroying proteins in cultured cells or cultured tissues and also facilitates nucleic acid release.

Furthermore, proteinase K also finds myriad use in purifying of genomic DNA from bacteria. With the thriving Whole Genome Synthesis Market, the Proteinase K industry is likely to gain traction in the years ahead. The enzyme activity towards native proteins is promoted by EDTA, SDS, and Urea. Proteinase K remains active in myriad temperature range and is more effective in the temperature ranging from 20 degree Celsius to 60 degree Celsius.

Proteinase K Market Growth Drivers

The expansion of Proteinase K market over the assessment period is attributed to large-scale funding by research organizations, pharma, and bio-pharma firms for promoting product innovations. Large-scale use of the enzyme in nucleic acid & mitochondria isolation will leverage the growth of proteinase k industry over the forecast timeframe.  Apparently, large-scale use of the enzyme in drug discovery as well as diagnosis of disease is predicted to favorably influence the proteinase K market size. Nonetheless, presence of nucleases & other proteins in proteinase K can impede the growth of the business in the upcoming years.

Furthermore, escalating demand for recombinant genes facilitating the manufacture of monoclonal anti-bodies will prompt proteinase k industry size over the ensuing years. Apparently, bio-pharma and pharma firms are focusing on creating new biological products from the enzyme, thereby providing the boost to the product penetration across the globe.

North America To Account Majorly Towards Overall Market Proceeds By 2026

The expansion of the Proteinase K market during the estimated timeframe is attributed to rise in the cancer cases in the nations like the U.S. Moreover, the occurrence of cancer has resulted in massive demand for next-generation sequencing technique & PCR technique that use proteinase K enzyme in the region, thereby steering the business trends in the sub-continent. Favorable schemes such as NSIGHT program introduced by National Human Genome Research Institute for screening infants for hereditary disorders have promoted the use of molecular biology procedure which involves proteinase K utilization. This, in turn, is expected to provide impetus to the regional industry growth over the forecast period.

Proteinase K Market: Competitive Players

Key participants profiled in the study are Advanced Enzymes Technologies Ltd., American Laboratories, Amicogen, Codexis, Inc., Affymetrix, BBI Solutions, Dyadic International, Amano Enzyme Inc., Biocatalysts Ltd., F. Hoffmann-La Roche Ltd., and Merck KGaA.

The global Proteinase K Market is segmented as follows:

By Form:

  • Powder
  • Liquid

By Therapeutic Area:

  • Neurology
  • Nephrology
  • Diabetes
  • Oncology
  • Contagious Diseases
  • Autoimmune Disease
  • Cardiology

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Proteinase K Market, 2016–2026 (USD Billion)
    • 2.2. Proteinase K Market: Snapshot
  • Chapter 3. Global Proteinase K Market– Industry Analysis
    • 3.1. Proteinase K Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. The expansion of Proteinase K market over the projected period is credited to allocation of huge funds by research organizations, pharma, and bio-pharma firms for adding new product features, thereby steering the market growth.
      • 3.2.2. Escalating demand for recombinant genes have prompted the production of monoclonal anti-bodies and this will propel proteinase k industry expansion over the upcoming years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Form
      • 3.4.2. Market attractiveness analysis By Therapeutic Area
  • Chapter 4. Global Proteinase K Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Proteinase K Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Proteinase K Market– Form Analysis
    • 5.1. Global Proteinase K Market overview: By Form
      • 5.1.1. Global Proteinase K Market share, By Form , 2019 and 2026
    • 5.2. Powder
      • 5.2.1. Global Proteinase K Market By Powder, 2016–2026 (USD Billion)
    • 5.3. Liquid
      • 5.3.1. Global Proteinase K Market By Liquid, 2016–2026 (USD Billion)
  • Chapter 6. Global Proteinase K Market– Therapeutic Area Analysis
    • 6.1. Global Proteinase K Market overview: By Therapeutic Area
      • 6.1.1. Global Proteinase K Market share, By Therapeutic Area , 2019 and 2026
    • 6.2. Neurulogy
      • 6.2.1. Global Proteinase K Market By Neurulogy, 2016–2026 (USD Billion)
    • 6.3. Nephrulogy
      • 6.3.1. Global Proteinase K Market By Nephrulogy, 2016–2026 (USD Billion)
    • 6.4. Diabetes
      • 6.4.1. Global Proteinase K Market By Diabetes, 2016–2026 (USD Billion)
    • 6.5. Onculogy
      • 6.5.1. Global Proteinase K Market By Onculogy, 2016–2026 (USD Billion)
    • 6.6. Contagious Diseases
      • 6.6.1. Global Proteinase K Market By Contagious Diseases, 2016–2026 (USD Billion)
    • 6.7. Autoimmune Disease
      • 6.7.1. Global Proteinase K Market By Autoimmune Disease, 2016–2026 (USD Billion)
    • 6.8. Cardiulogy
      • 6.8.1. Global Proteinase K Market By Cardiulogy, 2016–2026 (USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. American Laboratories
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfulio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Affymetrix
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfulio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. BBI Sulutions
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfulio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. Dyadic International
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfulio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Amicogen
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfulio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Biocatalysts Ltd.
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfulio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Advanced Enzymes Technulogies Ltd.
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfulio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. Amano Enzyme Inc.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfulio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. F. Hoffmann-La Roche Ltd.
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfulio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. Codexis, Inc.,
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product Portfulio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development
    • 7.11. Merck KGaA
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Product Portfulio
      • 7.11.4. Business Strategy
      • 7.11.5. Recent Development

Methodology


Frequently Asked Questions

The expansion of Proteinase K market over the assessment period is credited to humungous allocation of funds by research institutes, pharma companies, and bio-pharma firms for encouraging product developments. Large-scale use of the enzyme in nucleic acid & mitochondria isolation will favorably impact the growth of proteinase k market over the forecast timeframe.  Apart from this, large-scale use of the enzyme in drug discovery as well as diagnosis of disease is projected to lucratively influence the proteinase K market size.  

Furthermore, burgeoning demand for recombinant genes facilitating the manufacture of monoclonal anti-bodies will prompt proteinase k industry growth over the ensuing years. Apparently, bio-pharma and pharma firms are focusing on creating new biological products from the enzyme, thereby providing the boost to the product penetration across the globe.

According to Zion Market Research report, the global Proteinase K Market, which was estimated at 6.08 (USD Billion) in 2019 and is anticipated to accrue earnings worth 15.7 (USD Billion) by 2026, is set to record a CAGR of nearly 7.5% over 2020-2026.

North America is likely to make noteworthy contributions towards overall market revenue over the next couple of years. The growth of the market in the sub-continent over the estimated timeframe is credited to rise in the cancer cases in the nations like the U.S. Moreover, the high incidences of cancer has resulted in massive demand for next-generation sequencing technique & PCR technique that use proteinase K enzyme in the region, thereby steering the business trends in the sub-continent. Favorable schemes such as NSIGHT program introduced by National Human Genome Research Institute for screening infants for hereditary disorders have promoted the utility of molecular biology procedure that involves proteinase K utilization. This, in turn, is expected to provide impetus to the regional industry surge over the forecast timeline.

The key players profiled in the report include Advanced Enzymes Technologies Ltd., American Laboratories, Amicogen, Codexis, Inc., Affymetrix, BBI Solutions, Dyadic International, Amano Enzyme Inc., Biocatalysts Ltd., F. Hoffmann-La Roche Ltd., and Merck KGaA.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social